A switch from tenofovir disoproxil fumarate (TDF) to tenofovir alafenamide (TAF) in patients with HIV is associated with what percentage of weight gain?
≥ 5% weight gain
≤ 8% weight gain
≥ 10% weight gain
≤ 12% weight gain
